您的位置: 首页 > 农业专利 > 详情页

Formulations of human anti-RANKL antibodies, and methods of using the same
专利权人:
Amgen Inc.
发明人:
Brych, Stephen Robert,Wong, Lyanne M.,Fallon, Jaymille,Goss, Monica Michelle,Gu, Jian Hua,Ghattyvenkatakrishna, Pavan K.
申请号:
AU2018260750
公开号:
AU2018260750A1
申请日:
2018.04.27
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
Disclosed herein are aqueous pharmaceutical formulations comprising denosumab or another human anti-RANKL monoclonal antibody or portion thereof, and characteristics of pH, buffer systems, and amino acid aggregation inhibitors. Also disclosed are presentation of the formulation for use, e.g. in a single-use vial, single-use syringe, or glass container, methods of using the formulations and articles for preventing or treating diseases, and related kits.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充